Checks and balances exist across high-stakes sectors for a reason. Financial services, food safety, pharmaceuticals and environmental protection all rely on oversight because the consequences of failure are too serious to ignore. Artificial intelligence should be no different, especially in health care.
AI is one of the most powerful and least understood forces reshaping modern life. In health care, it is already influencing documentation, patient communication, risk prediction and clinical workflows and its potential is significant. AI can reduce administrative burden, improve efficiency and support clinical decision-making. But in a sector where decisions affect patient safety, trust and outcomes, potential is not enough. Tools that influence care must work reliably in real clinical environments, across patient populations and under the pressures of daily practice.
That is why the most important question in health care AI is no longer whether adoption will continue. It will. The real question is whether health care organizations have the governance, oversight and accountability needed to use these tools safely and responsibly.
Health care leaders have seen this dynamic before. New technologies often enter the field with bold promises of transformation. Organizations move quickly to capture efficiencies and improve performance. Then the harder reality sets in. Implementation is more complicated than expected, workflows are harder to adapt and governance matters to avoid missteps. AI heightens those challenges because it does not simply store information or automate administrative tasks. It can shape judgment. It can influence which patients the AI flags as high risk, how clinicians interpret information and what clinicians tell patients. At times, AI in health care can resemble an overconfident third-year medical student: helpful, but still quite capable of being wrong.
Used well, AI can strengthen care delivery. Used poorly, it can introduce risk at scale.
That’s why health care organizations can’t treat AI implementation as a standard technology purchase. It is an operational, clinical and governance issue. Before leaders embed an AI tool into patient care or core business functions, they should be able to answer a set of basic but critical questions: Who reviews the outputs? Who acts on them? Who escalates concerns, and how? Who monitors performance over time? Who informs patients when appropriate? When the answers are vague, accountability is vague too and patient safety can suffer.
Independent accreditation can help bring accountability to AI adoption. The nation’s first and only Health Care AI accreditation, developed by URAC for developers and users, provides a framework for governance, oversight, and ongoing monitoring.Responsible AI adoption depends on three elements working together: people, process and product.
- People: The first is people. Human oversight only works when the people using a tool understand enough about it to question it. Clinicians and staff do not need to become engineers, but they do need practical AI literacy. They should understand what the system is intended to do, where it may fall short and when clinicians or staff should challenge its output. Without that foundation, organizations often fall into one of two traps: overreliance because the technology appears advanced, or outright skepticism because it feels unfamiliar. Neither supports safe, consistent care.
- Process: Even a strong tool can create harm when an organization places it inside a weak workflow. Responsible adoption requires clear operational rules before roll-out, not after problems emerge. Organizations need defined processes for review, escalation, monitoring and quality improvement. They need clarity about who has oversight and what happens when performance concerns arise. In health care, an unclear process isn’t simply inefficient. It is unsafe.
- Product: Oversight doesn’t end at deployment. AI tools can drift over time, and their performance can vary across care settings, staffing models and patient populations. A model that performs well in development may behave differently in real-world use. Some of the most serious problems emerge over time, as bias goes unnoticed, false positives add burden and weak outputs become normalized in daily workflows. That makes monitoring, validation and recalibration essential. Health care leaders should approach AI with the same rigor they bring to other quality-sensitive functions.
Accountability also requires transparency. In health care, that means giving patients, clinicians and operational leaders clear information about what an AI tool is intended to do, where it may fall short and how the organization monitors it.
Organizations that succeed with AI will not be the ones that move fastest. They will be the ones that adopt with discipline, invest in workforce readiness, define ownership clearly and monitor performance continuously. In health care, trust is foundational to sustainable innovation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.